Boehringer Ingelheim's Survodutide Earns FDA Breakthrough Therapy Designation for MASH Treatment
CompanyDrug

Boehringer Ingelheim’s Survodutide Earns FDA Breakthrough Therapy Designation for MASH Treatment

Eli Lilly Appoints Thomas J. Fuchs as First Chief AI Officer to Lead AI Initiatives
Company

Eli Lilly Appoints Thomas J. Fuchs as First Chief AI Officer to Lead AI Initiatives

Zephyrm Bioscience Limited Files for IPO on Hong Kong Stock Exchange
CompanyDeals

Zephyrm Bioscience Limited Files for IPO on Hong Kong Stock Exchange

Pfizer Halts Development of Sisunatovir, an RSV Antiviral, After Phase II/III Trials
CompanyDrug

Pfizer Halts Development of Sisunatovir, an RSV Antiviral, After Phase II/III Trials

Biogen's China Unit Gets Conditional NMPA Nod for Qalsody (Tofersen) in ALS Treatment
CompanyDrug

Biogen’s China Unit Gets Conditional NMPA Nod for Qalsody (Tofersen) in ALS Treatment

Joincare Pharmaceutical Secures NMPA Approval for Triptorelin Microspheres to Treat Endometriosis
CompanyDrug

Joincare Pharmaceutical Secures NMPA Approval for Triptorelin Microspheres to Treat Endometriosis

CSPC Pharmaceutical Secures NMPA Approval for Omalizumab Biosimilar
CompanyDrug

CSPC Pharmaceutical Secures NMPA Approval for Omalizumab Biosimilar

Ningbo Menovo Pharmaceutical Partners with Nanjing Huawe Medicine for High-End Product Development
CompanyDeals

Ningbo Menovo Pharmaceutical Partners with Nanjing Huawe Medicine for High-End Product Development

CSPC Pharmaceutical's ADC CPO301 Earns Second Fast-Track Designation in the US for NSCLC Treatment
CompanyDrug

CSPC Pharmaceutical’s ADC CPO301 Earns Second Fast-Track Designation in the US for NSCLC Treatment

Bio-Thera Solutions Ltd Strikes Licensing Deal with Gedeon Richter for BAT1706 Biosimilar
CompanyDeals

Bio-Thera Solutions Ltd Strikes Licensing Deal with Gedeon Richter for BAT1706 Biosimilar

Jiangsu Aidea Pharmaceutical Secures NMPA Approval for Expanded Indication of Fubangde in HIV Treatment
CompanyDrug

Jiangsu Aidea Pharmaceutical Secures NMPA Approval for Expanded Indication of Fubangde in HIV Treatment

Ascentage Pharma Receives Approval for Two Phase III Trials of APG-2449 in NSCLC
CompanyDrug

Ascentage Pharma Receives Approval for Two Phase III Trials of APG-2449 in NSCLC